Stock listing

ABUS Stock Price, News, Filings & Events — Arbutus Biopharma Corporation

Selected listing: ABUS · NASDAQ · USD · US

This page tracks Arbutus Biopharma Corporation's ABUS:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following ABUS:NASDAQ. ABUS:NASDAQ is the stock-level entry point for investors researching Arbutus Biopharma Corporation, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Arbutus Biopharma Corporation, trading under the ticker ABUS, is a public company based in the United States with a market capitalization of approximately $865 million. The company focuses on developing innovative therapies for the treatment of viral infections, particularly hepatitis B. Arbutus is committed to advancing its research and development efforts to address unmet medical needs in this area.